3
Views
1
CrossRef citations to date
0
Altmetric
Proceedings of the Satellite Symposium, New Aspects of Renin Research

Local Inhibition of Angiotensin II Formation and Bradykinin Degradation in Isolated Hearts

&
Pages 1259-1270 | Published online: 23 May 2017

  • Lindpaintner K, Wilhelm MJ, Jin M, Unger Th, Lang RE, Scholkens BA, Ganten D: Tissue Renin-Angiotensin Systems: Focus on the Heart. J. Hypertens. 1987, 5 (Suppl 2): S33-S38.
  • Dzau VJ, Re NE: Evidence for the existence of renin in the heart. Circulation 1987, 75 (suppl. I): I-134-I-136.
  • Campbell DJ: Tissue Renin-Angiotensin System: Sites of Angiotensin Formation. J. Cardiovasc. Pharmacol 1987, 10 (suppl. 7): Sise.
  • Paul M, Wagner D, Metzger R, Ganten D, Lang RE, Suzuki F, Murakami K, Burbach JH, Ludwig G: Quantification of renin mRNA in various mouse tissues by a novel solution hybridization assay. J. Hypertens. 1988, 6: 247–252.
  • Linz W, Scholkens BA, Jin M, Wilhelm M, Ganten D: The Heart as a Target for Converting Enzyme Inhibitors: Studies in Ischemic Isolated Working Rat Hearts. J. Hypertens. 1986, 4 (suppl 6): S477-S479.
  • Linz W, Scholkens BA: Influence of Local Converting Enzyme Inhibition on Angiotensin and Bradykinin Effects in Ischemic Rat Hearts. J Cardiovasc Pharmacol. 1987, 10 (suppl 7): S75-S82.
  • Linz W, Scholkens BA, Han YF: Beneficial effects of the Converting Enzyme Inhibitor, Ramipril, in Ischemic Rat Hearts. J. Cardiovasc. Pharmacol. 1986, 8 (suppl. 10): S91-S99.
  • Vavrek RJ, Stewart JM: Competitive antagonists of bradykinin. Peptides 1985, 6: 161–164.
  • Heavey DJ, Barrow SE, Hickling NE, Ritter JM: Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature 1985, 318: 186–188.
  • Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327: 524–526.
  • Raish RJ, Smith DS, Owen WG: Secretion of plasminogen activator by the isolated perfused rat heart in response to vasoactive agents. Thromb Haemostasis 1985, 54: 170 (abstract).
  • Gilst WH van, Wijngaarden J van, Scholtens E, Graeff PA de, Langen CDJ de, Wesseling H: Captopril induced increase in coronary flow: An SH-dependent effect on arachidonic acid metabolism? J Cardiovasc. Pharmacol 1987, 9 (suppl 2): S31-S36.
  • Scherf H, Pietsch R, Landsberg G, Kramer HJ, Düsing R: Converting enzyme inhibitor ramipril stimulates prostacyclin synthesis by isolated rat aorta: Evidence for a kinin-dependent mechanism. Klin Wochenschr. 1986, 64: 742–745.
  • Schölkens BA, Gehring D: Inhibition of platelet aggregation by the converting enzyme inhibitor ramipril (Hoe 498) Hochdruck 1985, 6: 27 (abstract).
  • Albus U, Kujath W: Effect of angiotensinconverting enzyme inhibitor ramipril on noradrenaline-overflow from isolated working rat hearts subjected to myocardial ischemia and reperfusion. Naunyn Schmiedeberg's Arch Pharmacol 1987, 335 (Suppl): R82 (abstract) .
  • Carlsson L, Abrahamsson T: Ramiprilat attenuates local ischemia-induced release of noradrenaline via a reduction in angiotensin II generation and bradykinin degradation. J Mol Cell Cardiol 1988, in press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.